Rare diseases
Investigational molecules
Locations
Back to Denmark1 429 clinical trials in Copenhagen, Denmark across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)Study on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
BelgiumStudy of Patisiran for Patients with Transthyretin Amyloidosis and Heart Disease
DenmarkStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis
DenmarkStudy of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment
DenmarkStudy on the Safety and Effects of RP-1664 for Patients with Advanced Solid Tumors
DenmarkStudy of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety
DenmarkStudy on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation
DenmarkStudy of Encorafenib, Cetuximab, and Pembrolizumab for Patients with Untreated BRAF V600E-Mutant Metastatic Colorectal Cancer
DenmarkStudy of Tucatinib and Ado-Trastuzumab Emtansine for Patients with Advanced HER2+ Breast Cancer
DenmarkStudy on Enzalutamide and Leuprorelin Acetate for Men with High-Risk Nonmetastatic Prostate Cancer After Treatment
DenmarkStudy on Repotrectinib for Patients with Advanced Solid Tumors with ALK, ROS1, or NTRK1-3 Gene Changes
DenmarkStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
DenmarkThe busiest research cities in the country
What the registry says about research in the country
Clinical trial activity in København includes cardiovascular diseases, with studies focused on acute heart failure. The research is aimed at improving treatment choices and helping clinicians better manage fluid overload and treatment response.
These trials support more effective day-to-day management of patients with unstable heart conditions.
Research in digestive system diseases is centered on liver cirrhosis and its complications, especially ascites. The main purpose is to improve treatment planning and identify which patients are most likely to benefit from supportive therapy.
This work may help refine care for people with advanced liver disease.
Trials in the field of neoplasms are examining localised dMMR colon cancer. The research is focused on assessing treatment effectiveness and understanding how well patients respond to newer cancer approaches.
These studies aim to strengthen precision treatment for selected colorectal cancer patients.
Clinical research in nervous system diseases involves acute ischemic stroke. The goal is to improve urgent stroke care by comparing treatment approaches and their impact on early neurological recovery.
These trials are designed to support faster, more effective treatment decisions after stroke.
Research in virus diseases includes work on chronic hepatitis B infection, with studies exploring immune-based approaches and treatment effects. The overall aim is to improve control of long-term viral infection and related liver health.
These trials reflect active interest in advancing antiviral research in Denmark.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
